Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

…, AA Forastiere, G Adams, WA Sakr… - Journal of clinical …, 2023 - ingentaconnect.com
PURPOSE The Southwest Oncology Group (SWOG) coordinated an Intergroup study with
the participation of Radiation Therapy Oncology Group (RTOG), and Eastern Cooperative …

Epidemiology of prostate cancer.

GP Haas, WA Sakr - CA: a cancer journal for clinicians, 1997 - europepmc.org
Malignant transformation of the prostate and progression of carcinoma appear to be the
consequence of a complex series of initiation and promotional events under genetic and …

Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development: recommendations of the American association for …

…, AF Gazdar, LW Wattenberg, MB Sporn, WA Sakr… - Clinical Cancer …, 2002 - AACR
Precancer or intraepithelial neoplasia (IEN) is a noninvasive lesion that has genetic
abnormalities, loss of cellular control functions, and some phenotypic characteristics of invasive …

Her-2/neu Overexpression in Muscle-invasive Urothelial Carcinoma of the Bladder: Prognostic Significance and Comparative Analysis in Primary and Metastatic …

…, U Vaishampayan, P Tabazcka, WA Sakr… - Clinical Cancer …, 2001 - AACR
Purpose: The prognostic significance of Her-2/neu overexpression in muscle-invasive
urothelial carcinoma of the bladder is largely unknown. Accurate determination of Her-2/neu …

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy

…, JS LAM, LP DAVIS, DJ GRIGNON, WA SAKR… - The Journal of …, 1998 - auajournals.org
Purpose : Bone scintigrams of patients with increasing serum prostate specific antigen (PSA)
after radical prostatectomy are only rarely positive. We identify clinical parameters that …

[HTML][HTML] Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM

…, O Hassan, C Hwang, N Gupta, D Chitale, WA Sakr… - PloS one, 2012 - journals.plos.org
The emergence of castrate-resistant prostate cancer (CRPC) contributes to the high mortality
of patients diagnosed with prostate cancer (PCa), which in part could be attributed to the …

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus …

EC Skinner, B Goldman, WA Sakr… - The Journal of …, 2013 - auajournals.org
Purpose : Prior phase II studies of intravesical gemcitabine have shown it to be active and
well tolerated, but durable responses in patients with nonmuscle invasive bladder cancer who …

Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes

D Kong, S Sethi, Y Li, W Chen, WA Sakr, E Heath… - The …, 2015 - Wiley Online Library
BACKGROUND The mechanism(s) by which androgen receptor (AR) splice variants contribute
to castration‐resistant prostate cancer (CRPC) is still lacking. METHODS Expressions of …

Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival

WA Sakr, MV Tefilli, DJ Grignon, M Banerjee, J Dey… - Urology, 2000 - Elsevier
Objectives. Gleason score 7, in different proportions of grades 3 and 4, is the score most
frequently assigned to prostate cancer in our radical prostatectomy specimens (RPSs). We …

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917

JR Marshall, CM Tangen, WA Sakr, DP Wood Jr… - Cancer Prevention …, 2011 - AACR
The threat of prostate cancer and the significant and often negative impact of its treatment
underscore the importance of prevention. High-grade prostatic intraepithelial neoplasia (…